277 related articles for article (PubMed ID: 30747220)
41. LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.
Zhang Y; Luo Q; Wang N; Hu F; Jin H; Ge T; Wang C; Qin W
Med Oncol; 2015 May; 32(5):146. PubMed ID: 25814288
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
43. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
[TBL] [Abstract][Full Text] [Related]
45. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
Qiu X; Huang Y; Zhou Y; Zheng F
Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
[TBL] [Abstract][Full Text] [Related]
46. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
[TBL] [Abstract][Full Text] [Related]
47. Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion.
Jin C; Ye QH; Yuan FL; Gu YL; Li JP; Shi YH; Shen XM; Bo-Liu ; Lin ZH
Tumour Biol; 2015 Jun; 36(6):4309-17. PubMed ID: 25613068
[TBL] [Abstract][Full Text] [Related]
48. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
[TBL] [Abstract][Full Text] [Related]
49. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma.
Wang Y; Li W; Chen X; Li Y; Wen P; Xu F
Biomed Pharmacother; 2019 Mar; 111():1297-1301. PubMed ID: 30841443
[TBL] [Abstract][Full Text] [Related]
50. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
51. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
52. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.
Huang W; Gao F; Li K; Wang W; Lai YR; Tang SH; Yang DH
World J Gastroenterol; 2015 Mar; 21(10):3055-65. PubMed ID: 25780306
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
55. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
58. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
59. Long noncoding RNA MINCR regulates cellular proliferation, migration, and invasion in hepatocellular carcinoma.
Cao J; Zhang D; Zeng L; Liu F
Biomed Pharmacother; 2018 Jun; 102():102-106. PubMed ID: 29550632
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
Zhang L; Zhang T; Deng Z; Sun L
Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]